scholarly journals Correction: Transition metal substituted sandwich-type polyoxometalates with a strong metal–C (imidazole) bond as anticancer agents

2020 ◽  
Vol 56 (15) ◽  
pp. 2364-2364
Author(s):  
Hongxia Zhao ◽  
Li Tao ◽  
Fengmin Zhang ◽  
Ying Zhang ◽  
Yanqing Liu ◽  
...  

Correction for ‘Transition metal substituted sandwich-type polyoxometalates with a strong metal–C (imidazole) bond as anticancer agents’ by Hongxia Zhao et al., Chem. Commun., 2019, 55, 1096–1099.

2019 ◽  
Vol 55 (8) ◽  
pp. 1096-1099 ◽  
Author(s):  
Hongxia Zhao ◽  
Li Tao ◽  
Fengmin Zhang ◽  
Ying Zhang ◽  
Yanqing Liu ◽  
...  

The metal–carbon bond plays a pivotal role in the structural stabilities and biological activities of metal-based anticancer drugs. The strong M–Cimi bond is first introduced into sandwich-type POMs [Na0.7M5.3(H2O)2(imi)2(Himi)(SbW9O33)2]6−, (M = NiII (1), CoII (2), imi = imidazole).


2020 ◽  
Vol 26 (41) ◽  
pp. 7452-7475 ◽  
Author(s):  
Marta A. Andrade ◽  
Luísa M.D.R.S. Martins

: The development of safe and effective chemotherapeutic agents is one of the uppermost priorities and challenges of medicinal chemistry and new transition metal complexes are being continuously designed and tested as anticancer agents. Scorpionate ligands have played a great role in coordination chemistry, since their discovery by Trofimenko in the late 1960s, with significant contributions in the fields of catalysis and bioinorganic chemistry. Scorpionate metal complexes have also shown interesting anticancer properties, and herein, the most recent (last decade) and relevant scorpionate complexes reported for application in medicinal chemistry as chemotherapeutic agents are reviewed. The current progress on the anticancer properties of transition metal complexes bearing homo- or hetero- scorpionate ligands, derived from bis- or tris-(pyrazol-1-yl)-borate or -methane moieties is highlighted.


2005 ◽  
Vol 117 (14) ◽  
pp. 2196-2199 ◽  
Author(s):  
Si-Dian Li ◽  
Jin-Chang Guo ◽  
Chang-Qing Miao ◽  
Guang-Ming Ren

2009 ◽  
Vol 2009 (34) ◽  
pp. 5194-5204 ◽  
Author(s):  
Israel M. Mbomekalle ◽  
Pierre Mialane ◽  
Anne Dolbecq ◽  
Jérôme Marrot ◽  
Francis Sécheresse ◽  
...  

RSC Advances ◽  
2018 ◽  
Vol 8 (49) ◽  
pp. 28249-28260 ◽  
Author(s):  
Elham Naseri ◽  
Roushan Khoshnavazi

The A-type sandwich POMs of [(HOSnIVOH)3(PW9O34)2]12– (P2W18Sn3) and [(OCeIVO)3(PW9O34)2]12– (P2W18Ce3) were immobilized for the first time into the porous MIL-101 MOF. Their catalytic activities were examined in the oxidation of sulfides to sulfones at room temperature.


2019 ◽  
Vol 91 (4) ◽  
pp. 563-573 ◽  
Author(s):  
Marta Gozzi ◽  
Benedikt Schwarze ◽  
Evamarie Hey-Hawkins

Abstract Today, medicinal chemistry is still clearly dominated by organic chemistry, and commercially available boron-based drugs are rare. In contrast to hydrocarbons, boranes prefer the formation of polyhedral clusters via delocalized 3c2e bonds, such as polyhedral dicarba-closo-dodecaborane(12) (closo-C2B10H12). These clusters have remarkable biological stability, and the three isomers, 1,2- (ortho), 1,7- (meta), and 1,12-dicarba-closo-dodecaborane(12) (para), have attracted much interest due to their unique structural features. Furthermore, anionic nido clusters ([7,8-C2B9H11]2−), derived from the neutral icosahedral closo cluster 1,2-dicarba-closo-dodecaborane(12) by deboronation followed by deprotonation are suitable ligands for transition metals and offer the possibility to form metallacarboranes, for example via coordination through the upper pentagonal face of the cluster. The isolobal analogy between the cyclopentadienyl(–1) ligand (Cp−) and [C2B9H11]2− clusters (dicarbollide anion, Cb2−) is the motivation in using Cb2− as ligand for coordination to a metal center to design compounds for various applications. This review focuses on potential applications of half- and mixed-sandwich-type transition metal complexes in medicine.


2011 ◽  
Vol 130 (2-3) ◽  
pp. 237-250 ◽  
Author(s):  
Kazuhide Ichikawa ◽  
Ayumu Wagatsuma ◽  
Yusaku I. Kurokawa ◽  
Shigeyoshi Sakaki ◽  
Akitomo Tachibana

Sign in / Sign up

Export Citation Format

Share Document